Tariff Hikes On Chinese Imports Still In Play As US Plans December Increase
Trump administration negotiations with China representatives led to US suspending tariff increase to 25% on product categories announced set to begin 15 October. But 15% tariff added in September on about $112bn worth of Chinese goods remains and US still plans in December to impose separate 10% tariff hike on $160bn in other products.
You may also be interested in...
Hand sanitizer, vitamin, energy drink, first-aid kis and medical face mask sales soar globally as consumers fearing spread of the coronavirus stockpile food and other essentials, a Nielsen report shows. FDA says outbreak could lead to interruptions in drug and medical device supplies; agency has not addressed consumer health supplies specifically, and industry is increasingly concerned with availability.
Essential oils no longer on list of products slated for EU tariff increases effective 18 October, a win for US fragrance industry facing uncertainty in tumultuous global trade climate. Fragrancy industry, like dietary supplement manufacturers, still face higher tariffs on imports from China as next round of hikes is scheduled to start 15 October.
Consumer health industry groups plan to comment at June 17 public hearing on USTR plan for 25% tariff on imports from China not included in three earlier rounds of duties. NPA applauds USTR for allowing exclusion process for imported products valued at $200bn already hit with tariffs in 2018.